Ovintiv Inc OVV 深滬

等待開盤 03-26 09:30:00 美东时间

60.14

+1.170

+1.98%

華盛通

立即下載

最高60.15
今開58.09
成交量 365.25万股
最低 57.64
昨收 58.97
總市值 170.40亿
52周最高 60.15
市盈率 ^靜 12.58
換手率 1.29%
52周最低 28.60
委比 -71.43%
總股本 2.83亿
歷史最高 133.0325
量比 0.51
振幅 4.26%
歷史最低 -3.4488
每手 1
風險率 5.33%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

美股大行评级 | 潜在涨幅499.25%！Cabaletta Bio获Guggenheim升目标价至16美元，维持"买入"评级

今日重点评级关注：Guggenheim：维持Cabaletta Bio"买入"评级，目标价从15美元升至16美元；HC Wainwright & Co.：维持Palvella Therapeutics"买入"评级，目标价从255美元升至270美元

03-25 10:31
Truist Securities Initiates Coverage On Ovintiv with Buy Rating, Announces Price Target of $70

Truist Securities analyst Gabe Daoud initiates coverage on Ovintiv (NYSE:OVV) with a Buy rating and announces Price Target of $70.

03-25 00:10
Goldman Sachs Raises Oil Price Forecasts – Picks 7 Winners Among Energy Stocks

Goldman raised Brent to $100 for Q2 2026 and sees 22% average total return in top E&P names, anchored to a conservative $75/bbl mid-cycle assumption.

03-24 03:55
美股大行评级 | 最高700美元！大摩、瑞银等10家大行集体上调美光目标价；通用磨坊、梅西百货、SailPoint等遭多家大行下调目标价

今日重点评级关注：RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从32美元升至35美元；巴克莱：维持CytomX医疗"超配"评级，目标价从10美元升至16美元

03-20 15:53
美股大行评级 | 摩根大通上调哔哩哔哩至"超配"，目标价从27美元升至35美元；Rhythm遭花旗、大摩等多家机构下调目标价

今日重点评级关注：韦德布什：维持Black Diamond Therapeutic"跑赢大市"评级，目标价从13美元升至14美元；花旗：维持Olema Pharmaceuticals"买入"评级，目标价从60美元升至62美元

03-18 10:48
5 Oil and Gas Stocks That Benefit From Soaring Crude Prices

Energy sector benefits from rising oil prices due to war in Iran. Top oil and gas pipeline companies see soaring gains. 5 best-positioned stocks: Devon Energy and Ovintiv.

03-18 03:22
美股大行评级 | 能源股获大行青睐！美国铝业、康索尔能源、康菲石油、EOG能源等获上调目标价；多只航空股遭下调目标价

今日重点评级关注：HC Wainwright & Co.：维持Altimmune"买入"评级，目标价从12美元升至25美元；BTIG：维持Jade Biosciences"买入"评级，目标价从28美元升至39美元

03-17 11:45
Barclays Maintains Overweight on Ovintiv, Raises Price Target to $62

Barclays analyst Betty Jiang maintains Ovintiv (NYSE:OVV) with a Overweight and raises the price target from $58 to $62.

03-16 23:27
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics

U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics March 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Alnylam Pharmaceuticals, Cogent Biosciences and Summit Therapeutics on Monday

03-16 18:00
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级

今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元

03-12 12:34

派息除權日	每股總股息	派息日期
2026-03-13	0.30	2026-03-31
2025-12-15	0.30	2025-12-31
2025-09-15	0.30	2025-09-29
2025-06-13	0.30	2025-06-30
2025-03-14	0.30	2025-03-31
2024-12-13	0.30	2024-12-31
2024-09-13	0.30	2024-09-27
2024-06-14	0.30	2024-06-28
2024-03-14	0.30	2024-03-28
2023-12-14	0.30	2023-12-29
2023-09-14	0.30	2023-09-29
2023-06-14	0.30	2023-06-30
2023-03-14	0.25	2023-03-31
2022-12-14	0.25	2022-12-30
2022-09-14	0.25	2022-09-30
2022-06-14	0.25	2022-06-30
2022-03-14	0.20	2022-03-31
2021-12-14	0.14	2021-12-31
2021-09-14	0.14	2021-09-30
2021-06-14	0.09	2021-06-30
2021-03-12	0.09	2021-03-31
2020-12-14	0.09	2020-12-31
2020-09-14	0.09	2020-09-30
2020-06-12	0.09	2020-06-30
2020-03-12	0.09	2020-03-31
2019-12-12	0.02	2019-12-31
2019-09-12	0.02	2019-09-30
2019-06-13	0.02	2019-06-28
2019-03-14	0.02	2019-03-29
2018-12-13	0.01	2018-12-31
2018-09-13	0.01	2018-09-28
2018-06-14	0.01	2018-06-29
2018-03-14	0.01	2018-03-29
2017-12-14	0.01	2017-12-29
2017-09-14	0.01	2017-09-29
2017-06-13	0.01	2017-06-30
2017-03-13	0.01	2017-03-31
2016-12-13	0.01	2016-12-30
2016-09-13	0.01	2016-09-30
2016-06-13	0.01	2016-06-30
2016-03-11	0.01	2016-03-31
2015-12-11	0.07	2015-12-31
2015-09-11	0.07	2015-09-30
2015-06-11	0.07	2015-06-30
2015-03-11	0.07	2015-03-31
2014-12-11	0.07	2014-12-31
2014-09-11	0.07	2014-09-30
2014-06-11	0.07	2014-06-30
2014-03-12	0.07	2014-03-31
2013-12-11	0.07	2013-12-31
2013-09-11	0.20	2013-09-30
2013-06-12	0.20	2013-06-28
2013-03-13	0.20	2013-03-28
2012-12-12	0.20	2012-12-31
2012-09-12	0.20	2012-09-28
2012-06-13	0.20	2012-06-29
2012-03-13	0.20	2012-03-30
2011-12-13	0.20	2011-12-30
2011-09-13	0.20	2011-09-30
2011-06-13	0.20	2011-06-30
2011-03-11	0.20	2011-03-31
2010-12-13	0.20	2010-12-31
2010-09-13	0.20	2010-09-30
2010-06-11	0.20	2010-06-30
2010-03-11	0.20	2010-03-31
2009-12-17	0.20	2009-12-31
2009-09-11	0.40	2009-09-30
2009-06-11	0.40	2009-06-30
2009-03-12	0.40	2009-03-31
2008-12-11	0.40	2008-12-31
2008-09-11	0.40	2008-09-30
2008-06-11	0.40	2008-06-30
2008-03-12	0.40	2008-03-31
2007-12-12	0.20	2007-12-31
2007-09-12	0.20	2007-09-28
2007-06-13	0.20	2007-06-29
2007-03-13	0.20	2007-03-30
2006-12-13	0.10	2006-12-29
2006-09-13	0.10	2006-09-29
2006-06-13	0.10	2006-06-30
2006-03-13	0.08	2006-03-31
2005-12-13	0.08	2005-12-30
2005-09-13	0.08	2005-09-30
2005-06-13	0.08	2005-06-30
2005-03-11	0.10	2005-03-31
2004-12-13	0.10	2004-12-31
2004-09-13	0.10	2004-09-30
2004-06-14	0.10	2004-06-30
2004-03-11	0.10	2004-03-31
2003-12-10	0.08	2003-12-31
2003-09-10	0.07	2003-09-30
2003-06-11	0.07	2003-06-30
2003-03-12	0.07	2003-03-31
2002-12-11	0.06	2002-12-31
2002-09-11	0.06	2002-09-30
2002-06-12	0.07	2002-06-28
2002-03-13	0.06	2002-03-29
2001-12-06	0.06	2001-12-31

公司名稱	Ovintiv, Inc.
行業分類	Integrated Oil
業務描述	Ovintiv, Inc. engages in the production and development of oil, natural gas liquids and natural gas producing plays. The firm operates through the following segments: Canadian Operations and USA Operations. The Canadian Operations segment includes the exploration for, development of, and production of oil, NGLs, natural gas and other related activities within Canada. The USA Operations segment includes the exploration for, development of, and production of oil, NGLs, natural gas and other related activities within the United States. The company was founded in 1881 and is headquartered in Denver, CO.

Ovintiv Inc OVV 深 滬

60.14

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

Ovintiv Inc OVV 深滬